Acquired medical devices marketing license 2nd-class marketing license for medical devices

Escitalopram tablets 10 mg ‘Brio’ approved
Escitalopram tablets 20 mg ‘Brio’ approved

Ibandronate Intravenous Injection 1mg Syringe *VTRS* Launched

Ibandronate Intravenous Injection 1mg Syringe *VTRS*

Acquired 1st-class marketing license for pharmaceuticals.
Acquired 2nd-class marketing license for pharmaceuticals.
(Permit Number 13A1X10102, 13A2X10125)

Established